Filter Results
:
(26)
Show Results For
-
All HBS Web
(94)
- News (40)
- Research (26)
- Multimedia (3)
- Faculty Publications (9)
Show Results For
-
All HBS Web
(94)
- News (40)
- Research (26)
- Multimedia (3)
- Faculty Publications (9)
Page 1 of
26
Results
→
Sort by
- Research Summary
The Business of Stem Cells
By: Debora L. Spar
In 2004, the topic of stem cell research made both medical and moral headlines. Buoyed by a series of technological breakthroughs, stem cell scientists grew increasingly convinced that they would eventually be able to use embryonic stem cells -- the pluripotent cells...
View Details
- January 2009 (Revised February 2009)
- Case
Sydney IVF: Stem Cell Research
By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred
This case examines the strategy implementation and risk management decisions at Sydney IVF, a research-based in vitro fertilization and stem cell company based in Australia. Drs. Robert Jansen and Jock Anderson, who co-founded Sydney IVF in 1986, developed novel...
View Details
Keywords:
Ethics;
Governing Rules, Regulations, and Reforms;
Innovation and Management;
Growth and Development Strategy;
Risk Management;
Genetics;
Commercialization;
Health Industry;
Australia
Simons, Robert L., Kathryn Rosenberg, and Natalie Kindred. "Sydney IVF: Stem Cell Research." Harvard Business School Case 109-017, January 2009. (Revised February 2009.)
- November 2006 (Revised March 2008)
- Case
The Harvard Stem Cell Institute
Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how...
View Details
Keywords:
Talent and Talent Management;
Higher Education;
Entrepreneurship;
Collaborative Innovation and Invention;
Intellectual Property;
Research and Development;
Genetics;
Biotechnology Industry;
Health Industry;
Massachusetts
Sahlman, William A. "The Harvard Stem Cell Institute." Harvard Business School Case 807-096, November 2006. (Revised March 2008.)
- June 2010 (Revised May 2017)
- Teaching Note
Sydney IVF: Stem Cell Research
By: Robert Simons and Kathryn Rosenberg
Teaching Note for 109017.
View Details
Keywords:
Strategy And Execution;
Management Control Systems;
Levers Of Control;
Strategy;
Risk Management;
Decisions;
Cooperative Ownership;
Product Development;
Moral Sensibility;
Governing Rules, Regulations, and Reforms;
Expansion;
Science-Based Business;
Research;
Management Practices and Processes;
Business Subsidiaries;
Biotechnology Industry;
Sydney
- 2007
- Article
Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier
By: Debora Spar and Anna Harrington
Spar, Debora, and Anna Harrington. "Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier." American Journal of Law & Medicine 33, no. 4 (2007): 541–565.
- January 2009 (Revised July 2010)
- Case
iZumi
By: Robert F. Higgins, Jacob Ian Broder-Fingert, Eliot Sherman and Sidhartha Palani
Presents the issues faced while building an innovative company in an emerging space with new intellectual property from the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped...
View Details
- September 2020
- Case
Minerva 2010: Turbulent Times
By: John R. Wells and Benjamin Weinstock
In 2010, amid a flurry of new discoveries, Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), raised $6.6 million to test her new cancer drugs in mice. It had been more than 6 years since she had announced that she and her small team at...
View Details
Wells, John R., and Benjamin Weinstock. "Minerva 2010: Turbulent Times." Harvard Business School Case 721-390, September 2020.
- 31 Jul 2007
- First Look
First Look: July 31, 2007
small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and have a major impact in a large and underserved population. However, Vascugel had not...
View Details
Keywords:
Martha Lagace
- 19 Jun 2007
- First Look
First Look: June 19, 2007
questions the appropriate role for the AHA and cause marketing. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507026 The Harvard Stem Cell Institute Harvard Business...
View Details
Keywords:
Martha Lagace
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
Southeast Asia. China frequently makes the news for stem cell therapies that are not allowed in the West. So while I think India has some unique features it is not strictly unique. Q: What are the recruiting...
View Details
- Research Summary
Mastering Strategy Execution
By: Robert Simons
Professor Robert Simons’ research encompasses three areas of management accountability that are the foundation for successful strategy execution: organization design, performance measurement and control, and risk management. In addition, Simons is interested in the... View Details
- 05 Jan 2011
- Op-Ed
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress
get money. If they can't get money, they lay off people and cancel projects. Now imagine you are a postdoc in a lab and are working on a project to use human embryonic stem cells to cure diabetes by creating...
View Details
- 17 Dec 2001
- Research & Ideas
Enterprising Women
people," said Cynthia Fisher (HBS MBA '90). In 1993, using her own capital, Fisher founded ViaCord, a business that allows customers to bank cord blood stem cells for possible future use in the...
View Details
Keywords:
by Julia Hanna
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
facing leaders in those businesses." Another industry veteran, Professor of Management Practice Vicki Sato, led a discussion on "Emerging Models of University Research," with cases that looked at the Harvard-affiliated Whitesides Lab, View Details
- 20 Feb 2008
- First Look
First Look: February 20, 2008
provide evidence that they should self operates at a higher construal level (abstract, superordinate) than the want self, and that this difference in construal partly underlies previous future lock-in. Selling Stem View Details
Keywords:
Martha Lagace
- 29 May 2008
- Research & Ideas
Global Change in the Built Environment
away with? We had sessions on innovation, real estate derivatives, the history of housing crises, trade deficits, the global economy, business ethics, stem cell research, and China's role in the new world...
View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
for COVID-19 and is currently able to run 1,000 tests per day. David A. Ricks, CEO of Eli Lilly. Under Ricks’ guidance, Lilly has teamed with AbCellera Biologics to find antibodies to disarm COVID-19. Looking for the correct antibody sequence, they have screened 5...
View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
Meanwhile, those who are outside the market generally don't even know what's going on. Q: Are you worried that regulation could stifle innovation in reproductive medicines? A: Actually, I'm more worried about regulation in the stem View Details
- 01 Sep 2009
- First Look
First Look: September 1
the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped create iZumi Bio, a company with ambitious prospects that she believed had the potential to become "the"...
View Details
Keywords:
Martha Lagace
- 03 Mar 2009
- First Look
First Look: March 3, 2009
the Primary Dealer Credit Facility (PDCF), the Term Securities Lending Facility (TSLF), and the Asset Backed Commercial Paper Money Market Mutual Fund Liquidity Facility (AMLF). Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=709041...
View Details
Keywords:
Martha Lagace